Literature DB >> 31061254

Rare Case of Synchronous Cystic Duct Metastasis from Renal Cell Carcinoma.

Junji Ueda1, Hiroshi Makino1, Tadashi Yokoyama1, Hiroshi Maruyama1, Atsushi Hirakata1, Hideyuki Takata1, Natsuki Seki1, Yuta Kikuchi1, Masafumi Yoshioka1, Toshiyuki Irie1, Hiroshi Yoshida2.   

Abstract

INTRODUCTION: The common metastatic sites of renal cell cancer (RCC) are the lung, bone, liver, brain, adrenal glands, and contralateral kidney. Metastasis to the gallbladder is rare, and cystic duct metastasis from RCC has been reported in only one metachronous case. This is the first report of a case of synchronous cystic duct metastasis from RCC. CASE REPORT: A 72-year-old woman presenting with hematuria had a history of Cushing disease approximately 10 years previously. Enhanced computed tomography of the abdomen showed a mass measuring 5.8 × 3.0 cm in the left kidney, which was strongly enhanced in the early phase and washed out in the late phase. A mass measuring 2 cm in diameter was seen in the left adrenal gland, and a 1.0-cm mass was noted in the right adrenal gland. Multiple tiny masses were detected in the cystic duct. Left renal cell carcinoma, cystic duct metastasis, and bilateral adrenal gland metastases were diagnosed. Because the metastatic tumor was close to the common bile duct, we performed left nephrectomy, bilateral adrenalectomy, cholecystectomy, resection of the extrahepatic bile duct, and hepaticojejunostomy. Pathological findings showed that the renal tumor was clear cell carcinoma, as were the bilateral adrenal tumors and cystic duct tumor. The patient died 30 months after the operation.

Entities:  

Keywords:  cystic duct; metastasis; renal cell carcinoma

Mesh:

Year:  2019        PMID: 31061254     DOI: 10.1272/jnms.JNMS.2018_86-405

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  1 in total

1.  Cystic Duct Carcinoma: A New Classification System and the Clinicopathological Features of 62 Patients.

Authors:  Lingxi Nan; Changcheng Wang; Yajie Dai; Jie Wang; Xiaobo Bo; Shulong Zhang; Dexiang Zhang; Houbao Liu; Yueqi Wang
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.